Junken Aoki

29.8k total citations · 4 hit papers
396 papers, 21.5k citations indexed

About

Junken Aoki is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Junken Aoki has authored 396 papers receiving a total of 21.5k indexed citations (citations by other indexed papers that have themselves been cited), including 308 papers in Molecular Biology, 96 papers in Cell Biology and 87 papers in Physiology. Recurrent topics in Junken Aoki's work include Sphingolipid Metabolism and Signaling (207 papers), Lipid Membrane Structure and Behavior (68 papers) and Endoplasmic Reticulum Stress and Disease (57 papers). Junken Aoki is often cited by papers focused on Sphingolipid Metabolism and Signaling (207 papers), Lipid Membrane Structure and Behavior (68 papers) and Endoplasmic Reticulum Stress and Disease (57 papers). Junken Aoki collaborates with scholars based in Japan, United States and Ireland. Junken Aoki's co-authors include Hiroyuki Arai, Asuka Inoue, Kotaro Hama, Keizo Inoue, Kuniyuki Kano, Yasuhiro Kishi, Yutaka Yatomi, Shinichi Okudaira, Masafumi Tsujimoto and Kumiko Makide and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Junken Aoki

390 papers receiving 21.2k citations

Hit Papers

Autotaxin has lysophospholipase D activity leading to tum... 2002 2026 2010 2018 2002 2020 2019 2022 250 500 750

Peers

Junken Aoki
Andrew J. Morris United States
Timothy Hla United States
Lina M. Obeid United States
Richard Kolesnick United States
Michael J.O. Wakelam United Kingdom
Sue Goo Rhee United States
Daria Mochly‐Rosen United States
Christopher G. Proud United Kingdom
Andrew J. Morris United States
Junken Aoki
Citations per year, relative to Junken Aoki Junken Aoki (= 1×) peers Andrew J. Morris

Countries citing papers authored by Junken Aoki

Since Specialization
Citations

This map shows the geographic impact of Junken Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junken Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junken Aoki more than expected).

Fields of papers citing papers by Junken Aoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junken Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junken Aoki. The network helps show where Junken Aoki may publish in the future.

Co-authorship network of co-authors of Junken Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Junken Aoki. A scholar is included among the top collaborators of Junken Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junken Aoki. Junken Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shinjo, Yuji, Kuniyuki Kano, Kumiko Makide, et al.. (2025). Autocrine/paracrine lysophosphatidylserine signaling suppresses B cell aggregation and tertiary lymphoid structure formation. iScience. 28(5). 112420–112420. 1 indexed citations
2.
Hori, Tetsuya, et al.. (2025). Synaptic vesicle fusion promotes phosphatidylinositol 4-phosphate synthesis for efficient synaptic transmission. Cell Reports. 44(5). 115634–115634. 1 indexed citations
3.
Ohno, Osamu, Michiko Saito, Shinichi Kato, et al.. (2024). Suppression of Mast Cell Activation by GPR35: GPR35 Is a Primary Target of Disodium Cromoglycate. Journal of Pharmacology and Experimental Therapeutics. 389(1). 76–86. 2 indexed citations
4.
Izume, Tamaki, Akiharu Uwamizu, Hiroki Kawana, et al.. (2024). Structural basis for lysophosphatidylserine recognition by GPR34. Nature Communications. 15(1). 902–902. 9 indexed citations
5.
Kano, Kuniyuki, et al.. (2023). Lysophospholipids and their producing enzymes: Their pathological roles and potential as pathological biomarkers. Pharmacology & Therapeutics. 246. 108415–108415. 15 indexed citations
6.
Taneike, Manabu, Tomokazu Murakawa, Takahito Tamai, et al.. (2023). Lysophosphatidylserine induces necrosis in pressure overloaded male mouse hearts via G protein coupled receptor 34. Nature Communications. 14(1). 4494–4494. 3 indexed citations
7.
Kajitani, Naoto, Mami Okada‐Tsuchioka, Asuka Inoue, et al.. (2023). G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depression. Neuropsychopharmacology. 49(3). 561–572. 10 indexed citations
8.
Okuno, Toshiaki, Daisuke Saigusa, Kuniyuki Kano, et al.. (2022). Lysophosphatidic acid receptor_1/3 antagonist inhibits the activation of satellite glial cells and reduces acute nociceptive responses. Kyushu University Institutional Repository (QIR) (Kyushu University). 6 indexed citations
9.
Ohue‐Kitano, Ryuji, Akari Nishida, Daisuke Takahashi, et al.. (2022). Medium-chain fatty acids suppress lipotoxicity-induced hepatic fibrosis via the immunomodulating receptor GPR84. JCI Insight. 8(2). 19 indexed citations
10.
Hata, Saori, Kuniyuki Kano, Kazunori Kikuchi, et al.. (2021). Suppression of amyloid‐β secretion from neurons by cis ‐9, trans ‐11‐octadecadienoic acid, an isomer of conjugated linoleic acid. Journal of Neurochemistry. 159(3). 603–617. 6 indexed citations
11.
Nakamura, Sho, Akiharu Uwamizu, Yuko Otani, et al.. (2020). Non-naturally Occurring Regio Isomer of Lysophosphatidylserine Exhibits Potent Agonistic Activity toward G Protein-Coupled Receptors. Journal of Medicinal Chemistry. 63(17). 9990–10029. 11 indexed citations
13.
Fujii, T., Takeshi Nagamatsu, Danny J. Schust, et al.. (2019). Placental expression of lysophosphatidic acid receptors in normal pregnancy and preeclampsia. American Journal of Reproductive Immunology. 82(5). e13176–e13176. 11 indexed citations
14.
Nakanishi, Yoshimitsu, Asuka Inoue, K. Yanagida, et al.. (2018). Stepwise phosphorylation of leukotriene B4receptor 1 defines cellular responses to leukotriene B4. Science Signaling. 11(544). 13 indexed citations
15.
Ohkawa, Ryunosuke, Makoto Kurano, Noboru Sakai, et al.. (2018). Measurement of plasma choline in acute coronary syndrome: importance of suitable sampling conditions for this assay. Scientific Reports. 8(1). 4725–4725. 14 indexed citations
16.
Kuo, Bryan, Erzsébet Szabó, Sue Çhin Lee, et al.. (2018). The LPA2 receptor agonist Radioprotectin-1 spares Lgr5-positive intestinal stem cells from radiation injury in murine enteroids. Cellular Signalling. 51. 23–33. 19 indexed citations
17.
O’Hayre, Morgan, Kelsie Eichel, Silvia Avino, et al.. (2017). Genetic evidence that β-arrestins are dispensable for the initiation of β 2 -adrenergic receptor signaling to ERK. Science Signaling. 10(484). 159 indexed citations
18.
Guy, Adam T., Yasuko Nagatsuka, Noriko Ooashi, et al.. (2015). Glycerophospholipid regulation of modality-specific sensory axon guidance in the spinal cord. Science. 349(6251). 974–977. 91 indexed citations
19.
Aoki, Junken. (2003). [Mechanism of lysophosphatidic acid production].. PubMed. 75(7). 609–13. 2 indexed citations
20.
McIntyre, Thomas M., Adriana Ribeiro Silva, Yong Xu, et al.. (2002). Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARγ agonist. Proceedings of the National Academy of Sciences. 100(1). 131–136. 462 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026